Carbaril
Also known as carbaryl, this is a carbamate insecticide occasionally used in topical formulations to treat head lice infestations that are resistant to other agents. It inhibits the enzyme acetylcholinesterase in insects, disrupting their nervous system function. Its use in humans is limited and subject to regulatory restrictions due to potential toxicity.
Molekularmasse
201,2200 g/mol
LogP
2,40
TPSA
38,30 Ų
Lipinski-Regel der Fünf
Bestanden
Wirkmechanismus
Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.
2D-Struktur
Cite this structure
Embed this structure
SMILES
CNC(=O)Oc1cccc2ccccc12
InChI
InChI=1S/C12H11NO2/c1-13-12(14)15-11-8-4-6-9-5-2-3-7-10(9)11/h2-8H,1H3,(H,13,14)
Molecular Formula
C12H11NO2
HBD / HBA
1 / 2
Rotierbare Bindungen
2
Schwere Atome
15
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Häufig gestellte Fragen
Also known as carbaryl, this is a carbamate insecticide occasionally used in topical formulations to treat head lice infestations that are resistant to other agents. It inhibits the enzyme acetylcholinesterase in insects, disrupting their nervous system function. Its use in humans is limited and subject to regulatory restrictions due to potential toxicity.
Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.
Yes, Carbaril is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL46917. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 6129. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="carbaril"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/carbaril/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/carbaril/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/carbaril/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="carbaril"></drugfyi-drug>